Pays
Auteurs
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration Tocilizumab

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Japon1003
Kiyoshi Takasugi9
Japon Sauf Kiyoshi Takasugi" 994
Kiyoshi Takasugi Sauf Japon" 0
Japon Et Kiyoshi Takasugi 9
Japon Ou Kiyoshi Takasugi 1003
Corpus6869
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 9.
Ident.Authors (with country if any)Title
001B05 Masayoshi Souri [Japon] ; Sho Mokuda [Japon] ; Hiroshi Inanami [Japon] ; Tsukasa Osaki [Japon] ; Kiyoshi Takasugi [Japon] ; Akitada Ichinose [Japon]Non-autoimmune combined factor XIII A and B subunit deficiencies in rheumatoid arthritis patients treated with anti-interleukin-6 receptor monoclonal antibody (tocilizumab).
001E94 Atsushi Ogata [Japon] ; Tatsuya Atsumi [Japon] ; Takaaki Fukuda [Japon] ; Yasuhiko Hirabayashi [Japon] ; Masaaki Inaba [Japon] ; Naoki Ishiguro [Japon] ; Motokazu Kai [Japon] ; Daisuke Kawabata [Japon] ; Daihei Kida [Japon] ; Hitoshi Kohsaka [Japon] ; Ryutaro Matsumura [Japon] ; Seiji Minota [Japon] ; Masaya Mukai [Japon] ; Takayuki Sumida [Japon] ; Kiyoshi Takasugi [Japon] ; Shigenori Tamaki [Japon] ; Tsutomu Takeuchi [Japon] ; Atsuhisa Ueda [Japon] ; Kazuhiko Yamamoto [Japon] ; Hisashi Yamanaka [Japon] ; Hajime Yoshifuji [Japon] ; Akira Nomura [Japon]Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis.
002307 Sho Mokuda [Japon] ; Masamoto Kanno [Japon] ; Kiyoshi Takasugi [Japon] ; Chikara Okumura [Japon] ; Yuki Ito [Japon] ; Junya Masumoto [Japon]Tocilizumab improved clinical symptoms of a patient with systemic tophaceous gout who had symmetric polyarthritis and fever: An alternative treatment by blockade of interleukin-6 signaling.
002359 Norihiro Nishimoto [Japon] ; Koichi Amano ; Yasuhiko Hirabayashi ; Takahiko Horiuchi ; Tomonori Ishii ; Mitsuhiro Iwahashi ; Masahiro Iwamoto ; Hitoshi Kohsaka ; Masakazu Kondo ; Tsukasa Matsubara ; Toshihide Mimura ; Hisaaki Miyahara ; Shuji Ohta ; Yukihiko Saeki ; Kazuyoshi Saito ; Hajime Sano ; Kiyoshi Takasugi ; Tsutomu Takeuchi ; Shigeto Tohma ; Tomomi Tsuru ; Yukitaka Ueki ; Jiro Yamana ; Jun Hashimoto ; Takaji Matsutani ; Miho Murakami ; Nobuhiro TakagiRetreatment efficacy and safety of tocilizumab in patients with rheumatoid arthritis in recurrence (RESTORE) study.
002460 Norihiro Nishimoto [Japon] ; Koichi Amano ; Yasuhiko Hirabayashi ; Takahiko Horiuchi ; Tomonori Ishii ; Mitsuhiro Iwahashi ; Masahiro Iwamoto ; Hitoshi Kohsaka ; Masakazu Kondo ; Tsukasa Matsubara ; Toshihide Mimura ; Hisaaki Miyahara ; Shuji Ohta ; Yukihiko Saeki ; Kazuyoshi Saito ; Hajime Sano ; Kiyoshi Takasugi ; Tsutomu Takeuchi ; Shigeto Tohma ; Tomomi Tsuru ; Yukitaka Ueki ; Jiro Yamana ; Jun Hashimoto ; Takaji Matsutani ; Miho Murakami ; Nobuhiro TakagiDrug free REmission/low disease activity after cessation of tocilizumab (Actemra) Monotherapy (DREAM) study.
002475 Yasuaki Okuda [Japon] ; Makoto Ohnishi ; Kenichiro Matoba ; Kazuo Jouyama ; Akihiro Yamada ; Naoya Sawada ; Sho Mokuda ; Yousuke Murata ; Kiyoshi TakasugiComparison of the clinical utility of tocilizumab and anti-TNF therapy in AA amyloidosis complicating rheumatic diseases.
002673 Sho Mokuda [Japon] ; Yosuke Murata ; Naoya Sawada ; Kenichiro Matoba ; Akihiro Yamada ; Makoto Onishi ; Yasuaki Okuda ; Kazuo Jouyama ; Eiji Sugiyama ; Kiyoshi TakasugiTocilizumab induced acquired factor XIII deficiency in patients with rheumatoid arthritis.
003890 Dai Kishida [Japon] ; Yasuaki Okuda ; Makoto Onishi ; Masashi Takebayashi ; Kenichiro Matoba ; Kazuo Jouyama ; Akihiro Yamada ; Naoya Sawada ; Sho Mokuda ; Kiyoshi TakasugiSuccessful tocilizumab treatment in a patient with adult-onset Still's disease complicated by chronic active hepatitis B and amyloid A amyloidosis.
004244 Yasuaki Okuda [Japon] ; Kiyoshi Takasugi [Japon]Successful use of a humanized anti-interleukin-6 receptor antibody, tocilizumab, to treat amyloid A amyloidosis complicating juvenile idiopathic arthritis
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021